Xenetic Biosciences (XBIO) Net Margin (QoQ) (2012 - 2026)
Xenetic Biosciences (XBIO) Net Margin (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Xenetic Biosciences | 7.64 Mn | 1.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -122,483.00 |
| Mar 31, 2026 | -491,996.00 |
| Dec 31, 2025 | 403,228.00 |
| Sep 30, 2025 | 306,130.00 |
| Jun 30, 2025 | -4,426.00 |
| Mar 31, 2025 | -696,122.00 |
| Dec 31, 2024 | 652,167.00 |
| Sep 30, 2024 | -94,532.00 |
| Jun 30, 2024 | 235,273.00 |
| Mar 31, 2024 | -791,161.00 |
| Dec 31, 2023 | 641,464.00 |
| Sep 30, 2023 | -42,672.00 |
| Jun 30, 2023 | 36,405.00 |
| Mar 31, 2023 | -621,226.00 |
| Dec 31, 2022 | 779,600.00 |
| Sep 30, 2022 | 34,544.00 |
| Jun 30, 2022 | 12,332.00 |
| Mar 31, 2022 | -802,511.00 |
| Dec 31, 2021 | -17,946.00 |
| Sep 30, 2021 | 1.05 Mn |